In 2019, CEV and Andermatt Biocontrol started field trials in Switzerland to initiate PROBLAD™ registration.
Registration is expected to be approved before the end of 2023.
The swiss company, Andermatt Biocontrol is supporting CEV on PROBLAD™ development in Switzerland and will be the local distributor.
Please click on the logo to know more about Andermatt Biocontrol.
